Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PHF6 mutations in chronic myelomonocytic leukemia identify a unique subset of patients with distinct phenotype and superior prognosis.
Tefferi A, Fathima S, Alsugair AKA, Aperna F, Natu A, Abdelmagid MG, Csizmar CM, Gurney M, Lasho TL, Finke CM, Mangaonkar AA, Al-Kali A, Pardanani A, Reichard KK, He R, Gangat N, Patnaik MM. Tefferi A, et al. Among authors: gurney m. Am J Hematol. 2024 Dec;99(12):2321-2327. doi: 10.1002/ajh.27492. Epub 2024 Sep 27. Am J Hematol. 2024. PMID: 39329442
The impact of cytotoxic therapy on the risk of progression and death in clonal cytopenia(s) of undetermined significance.
Li M, Baranwal A, Gurney M, Shah SN, Al-Kali A, Alkhateeb H, Foran J, Arana Yi C, Ongie L, Chen D, Mangaonkar A, McCullough K, Tefferi A, Lasho T, Finke C, Patnaik MM, Shah MV. Li M, et al. Among authors: gurney m. Blood Adv. 2024 Jun 25;8(12):3130-3139. doi: 10.1182/bloodadvances.2023012357. Blood Adv. 2024. PMID: 38564774 Free PMC article.
ASXL1/TET2 genotype-based risk stratification outperforms ASXL1 mutational impact and is independent of mutant variant allele fractions in chronic myelomonocytic leukemia.
Csizmar CM, Gurney M, Kanagal-Shamanna R, Chien K, Hammond D, Lasho TL, Finke CM, Dean C, Natu A, Mangaonkar AA, Al-Kali A, Gangat N, Tefferi A, Alkhateeb H, Garcia-Manero G, Komrokji RS, Ali NA, Padron E, Montalban-Bravo G, Patnaik MM. Csizmar CM, et al. Among authors: gurney m. Haematologica. 2024 Oct 1;109(10):3419-3425. doi: 10.3324/haematol.2024.285410. Haematologica. 2024. PMID: 38899337 Free PMC article. No abstract available.
Clinical and molecular spectrum and prognostic outcomes of U2AF1 mutant clonal hematopoiesis- a prospective mayo clinic cohort study.
Pritzl SL, Gurney M, Badar T, Ferrer A, Lasho T, Finke C, Mangaonkar A, McCullough K, Gangat N, Fernandez J, Al-Kali A, Viswanatha D, He R, Foran J, Patnaik MM. Pritzl SL, et al. Among authors: gurney m. Leuk Res. 2023 Feb;125:107007. doi: 10.1016/j.leukres.2022.107007. Epub 2022 Dec 28. Leuk Res. 2023. PMID: 36586169 No abstract available.
Genetic landscape and clinical outcomes of patients with BCOR mutated myeloid neoplasms.
Baranwal A, Gurney M, Basmaci R, Katamesh B, He R, Viswanatha DS, Greipp P, Foran J, Badar T, Murthy H, Yi CA, Palmer J, Mangaonkar AA, Patnaik MM, Litzow MR, Hogan WJ, Begna K, Gangat N, Tefferi A, Al-Kali A, Shah MV, Alkhateeb HB. Baranwal A, et al. Among authors: gurney m. Haematologica. 2024 Jun 1;109(6):1779-1791. doi: 10.3324/haematol.2023.284185. Haematologica. 2024. PMID: 38299584 Free PMC article.
233 results